• Prof. Vassillios Fanos on Metabolomics and Microbiomics

    Prof. Fanos, addresses how COVID-19, AI, Big Data and the future of medicine may impact our relation with the microbiome.

  • Fitness trackers show low physical activity in musculoskeletal disease patients

    Musculoskeletal disease patients manage moderate-to-vigorous physical training, but fail the recommended daily steps.

  • France: Junior mountaineers seek physicians

    “À Chacun Son Everest!” organises trips that are of great inspiration for the children and women in remission joining; and for the physicians travelling with them.

  • Bladder cancer: Robotic surgery shortens post-op hospital stays

    Post-surgery hospital stay was much shorter for bladder cancer patients after full robotic radical cystectomy over those treated with open surgery.

  • Sexual dysfunction prevalent in RA and PsA patients

    According to a Spanish study, patients with rheumatoid arthritis and psoriatic arthritis have a markedly deteriorated sexual life compared with a healthy population.

  • IL-6 inhibition successful in polymyalgia rheumatica

    Sarilumab demonstrated positive results in a phase 3 trial for PMR patients. More participants reached sustained remission and reduced flare risk.

  • Treatment with bimekizumab beneficial in psoriatic arthritis

    The IL-17A/IL-17F blocker bimekizumab showed marked superiority in the primary and all ranked secondary endpoints of the phase 3 BE OPTIMAL trial as a PsA therapy.

  • Global safety report: more VTE events on JAK inhibition in rheumatoid arthritis

    A register study explored worldwide data on MACEs and venous thromboembolism associated with JAK inhibitors compared to anti-TNF agents in RA.

  • My DNA: Where Did My Ancestors Come From? (Part 2)

    Prof. Dr. Reinhard Renneberg uses his own DNA as an example to show which migratory routes his earliest ancestors took.

  • Antifibrotic therapy effective in patients with negative lung function prognostics

    A post-hoc trial analysis revealed nintedanib treatment benefit in patients with 4 characteristics associated with a fast decline in lung function.

  • Steep increase of mortality in RA patients with comorbid depression

    A large register study in Denmark detected a substantially higher mortality risk for patients with rheumatoid arthritis (RA) who had comorbid depression.

  • TYK2 inhibition: A rising star in lupus therapy?

    Deucravacitinib showed convincing results as a treatment for patients with active systemic lupus erythematosus (SLE) in the phase 2 PAISLEY trial.

  • RA: Several risk factors identified for incident dementia

    Cohort study data detected factors linked to a risk amplification for dementia development in patients with rheumatoid arthritis.

  • Baricitinib shows great potential in juvenile idiopathic arthritis

    During the double-blind period of a withdrawal trial, baricitinib demonstrated predominance over placebo in the prevention of disease flares.

  • JAK inhibitor shows to be effective in non-radiographic axSpA

    Once-daily therapy with upadacitinib led to an ASAS40 response in 45% of patients with active nr-axSpA at week 14 in the SELECT-AXIS-2 trial.

  • Prof. Lorenzo Brunetti: Artificial intelligence and ethical dilemmas in hematology

    esanum talks with Prof. Brunetti about AI in medicine, its ethical implications and physicians' approach to this tech revolution.

  • DA-EPOCH-R: less toxic than CODOX-M/R-IVAX in high-risk Burkitt lymphoma

    Trial results show equal DA-EPOCH-R efficacy to CODOX-M/R-IVAX as first-line treatment in patients, but less toxicity.

  • Prof. Antonio Almeida: Academic knowledge disseminates in no time

    New technologies have transformed haematology. Gene-editing and molecular agents become available to patients within shorter timeframes.

  • Can ACE Inhibitors Help Prevent Renal Crisis in Scleroderma?

    A Chinese meta-analysis of studies on the treatment of scleroderma has investigated whether ACE inhibitors can be used to prevent renal crisis.

  • Prof. Maria Chiara Bonini: Gene therapy applied to immunotherapy

    esanum talks with Prof. Bonini about her research projects, her EHA board role and the prospects for young hematologists who wish to engage in research.

  • 7 |
  • 8 |
  • 9 |
  • 10 |
  • 11 |
  • 12 |
  • 13 |
  • 14 |
  • 15 |
  • 16 |
  • 17 |